trial · primary record
VXCO-102
EBV
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 82 |
| Primary completion | 2028-02-29 |
| Primary endpoint | Number of Participants with Solicited Local and Systemic Reactions |
| Registry ID | NCT07557602 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:42.738Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07557602
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.